BioClinica Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BioClinica Inc. - overview
Established
1990
Location
Princeton, NJ, US
Primary Industry
Healthcare IT
About
BioClinica Inc. is a leading provider of endpoint technology services for clinical trials, dedicated to improving trial efficiency and data integrity through advanced imaging analysis and eCOA solutions. BioClinica Inc. focuses on delivering innovative clinical trial management solutions.
Founded in 1990 in Princeton, US, the company has engaged in three deals, with its most recent deal occurring on December 7, 2020. In this transaction, BioClinica merged with eResearchTechnology Inc. to form Clario, a strategic move aimed at enhancing its growth. The firm has successfully raised a total amount of USD 1,400.
00 mn through multiple funding rounds, with the latest round being a Secondary Buyout led by Cinven. BioClinica provides extensive endpoint technology services crucial for clinical trial management, emphasizing improved quality and operational efficiency. Their offerings encompass advanced imaging analysis, electronic Clinical Outcome Assessments (eCOA), and artificial intelligence solutions tailored to optimize data collection and patient safety. With a global presence, BioClinica supports a diverse clientele, including biopharmaceutical companies and contract research organizations, operating across over 100 countries.
Their solutions are adaptable for both decentralized and hybrid clinical trial models. In its most recent fiscal year, BioClinica reported a revenue of USD 98. 28 mn, with an EBITDA of USD 11. 76 mn.
The company primarily generates revenue through business-to-business transactions involving long-term partnerships with pharmaceutical companies and CROs, leveraging subscription-based service models for clinical trial management. Looking ahead, BioClinica plans to leverage its recent merger with eResearchTechnology to enhance its product offerings and market reach. The combination aims to support Clario's growth in the clinical trial sector. The firm is expected to explore new markets and expand its geographic footprint, although specific regions have yet to be disclosed.
Funding from the Secondary Buyout will be utilized to foster these growth initiatives, enhancing capabilities in endpoint technology and further improving trial efficiencies.
Current Investors
Clario
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Medical Software
Verticals
Cloud Computing
Company Stage
Merged
Total Amount Raised
Subscriber access only
BioClinica Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Merger | Completed | BioClinica Inc., eResearchTechnology Inc. | - | ||||||||
| Add-on, Trade Sale | Completed | BioClinica Inc.'s Clinical Research Site Business | - | ||||||||
| Add-on | Completed | MDDX | - | ||||||||
| Secondary Buyout | Completed | BioClinica Inc. | - | ||||||||
| Add-on | Completed | Compass Research | - |
Displaying 1 - 5 of 11
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.